{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000910","form_type":"8-K","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-07-06T12:46:06+00:00","discovered_at":"2026-07-06T12:50:00.231797+00:00","generated_at":"2026-07-06T12:50:05.560997+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Splash Beverage acquires exclusive global rights to CannEpil epilepsy therapy from Argent BioPharma","bullets":["Exclusive global license for CannEpil, a cannabinoid-based therapy for drug-resistant epilepsy already used in Europe.","Consideration includes $1M investment from C/M Capital, $5M debt forgiveness, and $5.5M preferred equity issuance.","Argent BioPharma to receive 15% royalty on net revenue from worldwide sales of CannEpil.","CannEpil has FDA pre-IND engagement and an IND number for U.S. clinical development.","Drug-resistant epilepsy affects ~30% of epilepsy patients; therapy has EU-GMP manufacturing and European patient access."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000910","json":"https://secwatch.observer/filing/0001731122-26-000910.json","markdown":"https://secwatch.observer/filing/0001731122-26-000910.md","text":"https://secwatch.observer/filing/0001731122-26-000910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000910/0001731122-26-000910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000910/e7759_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T12:50:05.560997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}